Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06517186 · ClinicalTrials.gov registry record
Myocardial Mechanisms in Heart Failure With Preserved Ejection Fraction
A clinical trial of Heart Failure and Heart Failure With Preserved Ejection Fraction, sponsored by Northwestern University.
- Recruiting
- Registry status
- 180
- Enrollment target
- 6
- Study locations
NCT06517186 is a study of Heart Failure and Heart Failure With Preserved Ejection Fraction that is actively recruiting participants, run by Northwestern University. The registered enrollment target is 180 participants, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (91% lower). The trial reports 6 study locations across 6 states.
The verdict
NCT06517186, a study of Heart Failure and Heart Failure With Preserved Ejection Fraction, is actively recruiting participants, sponsored by Northwestern University.
- RECRUITING
- Registry status
- 180 participants
- Enrollment target
- 6
- Study locations
Study Summary
The purpose of this study is to identify changes in heart tissue structure and biological function in patients with heart failure by performing an endomyocardial biopsy (EMB or heart biopsy) during a right heart catheterization (RHC). The ultimate goal is to use this information to develop new treatments for heart failure.
Conditions Studied
Study Locations (6)
Illinois
- Northwestern University - Chicago
Maryland
- Johns Hopkins University - Baltimore
Massachusetts
- Mass General Brigham - Boston
Minnesota
- Mayo Clinic - Rochester
North Carolina
- Wake Forest University - Winston-Salem
Pennsylvania
- University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2024-11-08 |
| Est. Completion | 2026-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06517186
The ClinicalTrials.gov registry entry for NCT06517186 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 180 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (91% lower). The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Heart Failure appearing as the primary indexed condition, and to 0 interventions.
NCT06517186 reports 6 study locations spanning 6 distinct geographic areas - top geographies include Illinois, Maryland, Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06517186 about?
NCT06517186 is a clinical study titled "Myocardial Mechanisms in Heart Failure With Preserved Ejection Fraction". The purpose of this study is to identify changes in heart tissue structure and biological function in patients with heart failure by performing an endomyocardial biopsy (EMB or heart biopsy) during a right heart catheterization (RHC). The ultimate goal is to use this information to develop new treat...
What is the current status of trial NCT06517186?
This trial is currently recruiting. The enrollment target is 180 participants. The study started on 2024-11-08. Estimated completion is 2026-06.
What conditions does trial NCT06517186 study?
This clinical trial studies the following conditions: Heart Failure, Heart Failure With Preserved Ejection Fraction.
Who is sponsoring clinical trial NCT06517186?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06517186 being conducted?
This trial has 6 study locations across Illinois, Maryland, Massachusetts, Minnesota, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients with Heart Failure Who Are Intolerant or Not Eligible for Treatment with Steroidal Mineralocorticoid Receptor Antagonists
RECRUITING · Phase 3
-
Circulating Markers That Underlie the Transition From Compensated Hypertrophy to Heart Failure
RECRUITING
-
Integration of Telemedicine and Home-Based Cardiac Rehabilitation: Feasibility, Efficacy, and Adherence
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.